DURHAM, NC--(Marketwire - October 15, 2008) - Aldagen, Inc. today announced the appointment of Lyle Hohnke, Ph.D. to its Board of Directors. Dr. Hohnke has over 35 years of health care industry experience, focusing on biotechnology, pharmaceuticals and medical devices. He has been a partner of Tullis Dickerson, a healthcare focused venture capital fund, since 1994 and currently serves on the board of several private and public companies.
